Human Papillomavirus-Related Carcinoma Clinical Trial
Official title:
Clinical Decision Support Tools to Increase HPV Vaccination in Pharmacies
This clinical trial develops and tests how well a clinical decision support (CDS) tool works to increase human papillomavirus (HPV) vaccination of children between the age of 9-17 (adolescents) in pharmacies. HPV vaccination rate in eligible adolescents remains low even though over 90% of the cancers in adults caused by HPV can be prevented by the HPV vaccine. The National Vaccine Advisory Committee recommends HPV vaccinations to be given in pharmacies to increase access to vaccines, but pharmacy processes and lack of awareness of the service among parents impact the use of local pharmacies for HPV vaccinations. Using a focus group may be an effective method to develop a CDS tool and create a process that may be more convenient for parents to get their adolescent's vaccine at their local pharmacy. A CDS tool may make it easier to obtain HPV vaccines, and as a result increase the adolescent HPV vaccination rate and reduce the incidence of cancer caused by HPV.
OUTLINE: Participants are assigned to 1 of 3 groups. Group I: Staff participate in facilitated planning discussions to develop CDS tools on study. (Aim I) Group II: Staff receives CDS tools training and implements CDS tools to facilitate HPV vaccination on study. (Aim II) Group III: Parents complete survey post-intervention on study. (Aim II) ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02379520 -
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
|
Phase 1 | |
| Completed |
NCT02624349 -
Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients
|
Phase 4 | |
| Recruiting |
NCT04474821 -
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
|
Phase 4 | |
| Withdrawn |
NCT05472220 -
Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma
|
Phase 1 | |
| Active, not recruiting |
NCT02568566 -
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants
|
Phase 2 | |
| Recruiting |
NCT05232851 -
A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05985681 -
Testing RG1-VLP Vaccine to Prevent HPV-related Cancers
|
Phase 1 | |
| Completed |
NCT04189003 -
Molecular Signatures of HPV+ ORL Cancers (OROPAP)
|
||
| Recruiting |
NCT04927650 -
Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening
|
||
| Completed |
NCT01769560 -
MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
|
N/A | |
| Active, not recruiting |
NCT04580446 -
HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT03634267 -
MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
|
Phase 1 | |
| Not yet recruiting |
NCT04142398 -
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men
|
||
| Completed |
NCT04880837 -
Human Papillomavirus Education Programs
|
N/A |